<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="a CC50 value &amp;gt;100 μg/mL. Of the five drugs, only" exact="amantadine" post="(IC50: 1 ± 0.42 μg/mL, TI: 100) and ribavirin"/>
 <result pre="only amantadine (IC50: 1 ± 0.42 μg/mL, TI: 100) and" exact="ribavirin" post="(IC50: 22 ± 1.36 μg/mL, TI: 4.55) had any"/>
 <result pre="inhibitors (amantadine and rimantadine), and neuramidase inhibitors (oseltamivir and zanaminir)." exact="Ribavirin" post="is licensed for the treatment of respiratory syncytial virus"/>
 <result pre="Biosystems). The products were purified by precipitation with 100% cold" exact="ethanol" post="and 3 M sodium-acetate (pH 5.8), then loaded on"/>
 <result pre="previously described and recently reported by Choi et al [18-20]." exact="Ribavirin" post="was purchased from DUCHEFA (Netherlands); azidothymidine, acyclovir, amantadine, and"/>
 <result pre="Ribavirin was purchased from DUCHEFA (Netherlands); azidothymidine, acyclovir, amantadine, and" exact="lamivudine" post="were purchased from Sigma-Aldrich (St. Louis, MO, USA), as"/>
 <result pre="the five antiviral drugs at a CC50 value &amp;gt;100 μg/mL." exact="Amantadine" post="and ribavirin exhibited antiviral activity against the Korean ECV"/>
 <result pre="antiviral drugs at a CC50 value &amp;gt;100 μg/mL. Amantadine and" exact="ribavirin" post="exhibited antiviral activity against the Korean ECV 5 strain,"/>
 <result pre="against the Korean ECV 5 strain, though azidothymidine, acyclovir, and" exact="lamivudine" post="did not. The amantadine possessed an IC50 value of"/>
 <result pre="5 strain, though azidothymidine, acyclovir, and lamivudine did not. The" exact="amantadine" post="possessed an IC50 value of 1 ± 0.42 μg/mL"/>
 <result pre="0.42 μg/mL and a TI value of 100, while the" exact="ribavirin" post="possessed an IC50 value of 22 ± 1.36 μg/mL"/>
 <result pre="antiviral drugs against Korean echovirus 5 Compounds IC50a CC50b TIc" exact="Azidothymidine" post="NDd &amp;gt;100 - Acyclovir NDd &amp;gt;100 - Amantadine 1"/>
 <result pre="CC50b TIc Azidothymidine NDd &amp;gt;100 - Acyclovir NDd &amp;gt;100 -" exact="Amantadine" post="1 ± 0.42 &amp;gt;100 100 Lamivudine NDd &amp;gt;100 -"/>
 <result pre="Acyclovir NDd &amp;gt;100 - Amantadine 1 ± 0.42 &amp;gt;100 100" exact="Lamivudine" post="NDd &amp;gt;100 - Ribavirin 22 ± 1.36 &amp;gt;100 4.55"/>
 <result pre="Amantadine 1 ± 0.42 &amp;gt;100 100 Lamivudine NDd &amp;gt;100 -" exact="Ribavirin" post="22 ± 1.36 &amp;gt;100 4.55 These results are the"/>
 <result pre="drugs tested here (azidothymidine, acyclovir, amantadine, lamivudine, and ribavirin), only" exact="amantadine" post="(IC50: 1 μg/mL) and ribavirin (IC50: 22 μg/mL) had"/>
 <result pre="amantadine, lamivudine, and ribavirin), only amantadine (IC50: 1 μg/mL) and" exact="ribavirin" post="(IC50: 22 μg/mL) had antiviral activity against Korean ECV"/>
 <result pre="22 μg/mL) had antiviral activity against Korean ECV 5, with" exact="amantadine" post="showing stronger effects than ribavirin. Therefore, the amantadine and"/>
 <result pre="5, with amantadine showing stronger effects than ribavirin. Therefore, the" exact="amantadine" post="and ribavirin could be applied to patients infected with"/>
 <result pre="amantadine showing stronger effects than ribavirin. Therefore, the amantadine and" exact="ribavirin" post="could be applied to patients infected with ECV 5."/>
 <result pre="patients infected with ECV 5. It was reported that the" exact="amantadine" post="could suppress the IRES mediated translation, and ribavirin is"/>
 <result pre="that the amantadine could suppress the IRES mediated translation, and" exact="ribavirin" post="is a nucleoside analogue with broad-spectrum antiviral activity by"/>
</results>
